<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43668">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02537821</url>
  </required_header>
  <id_info>
    <org_study_id>PKSF-01-2014</org_study_id>
    <nct_id>NCT02537821</nct_id>
  </id_info>
  <brief_title>HLA Sensitization in Severely Burned Patients</brief_title>
  <official_title>HLA Sensitization in Severely Burned Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      Primary goal of this study is the analysis of HLA (Human leucocyte antigen) formation in
      severly burned patients. Potential HLA triggers in the treatment of severely burned patients
      are blood products, assist devices or temporary allogeneic skin. Besides that, inflammatory
      markers, such as WBC (white blood cell count), CRP (C-reactive protein), PCT (Procalcitonin)
      and two novel biomarkers (PSP (pancreatic stone protein), ST2) are to be investigated in
      severely burned patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HLA antibody formation (HLA Sensitization) (Unit: PRA in %)</measure>
    <time_frame>Change from Baseline (admission) in HLA antibody count at 2 weeks, 4 weeks, 3 months and 6 months</time_frame>
    <description>The degree of sensitization is reported as the percentage of CDC (Complement dependent Cytotoxicity) Panel Reactive Antibody (PRA). Unit is %.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Severely Burned Patients</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Severely burned patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  severely burned patients in need for hospitalization

        Exclusion Criteria:

          -  hematologic diseases

          -  Cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Plock, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Raemistrasse 100, 8091</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Plock, M.D.</last_name>
    <phone>0041 (0)44 2551111</phone>
    <email>jan.plock@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Plock, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 10, 2016</lastchanged_date>
  <firstreceived_date>July 1, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
